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A B S T R A C T
Background: The possible role of Helicobacter pylori (HP) infection in extra-intestinal diseases has been
suggested. The main purpose of this study was to determine the frequency of infection with HP in two
groups of patients with epilepsy: patients with idiopathic generalized epilepsy (IGE) and patients with
temporal lobe epilepsy (TLE), compared to healthy controls.
Methods: In this cross-sectional study a random sample of adult patients above 18 years of age with a
diagnosis of IGE or TLE were recruited at the outpatient epilepsy clinic at Shiraz University of Medical
Sciences, from January 2009 through June 2011. A group of healthy individuals were included as control
group. For all patients and controls a urea breath test (UBT) was requested.
Results: Thirty-four patients with IGE, 28 patients with TLE and 33 individuals as control were recruited.
Positive UBT was observed in 21 individuals (61.8%) with IGE, 50% (14 patients) of patients with TLE and
72.7% (24 individuals) in control group. The difference between patients with IGE and control group was
not signiﬁcant (P = 0.3). The difference between patients with TLE and control group was not signiﬁcant
either (P = 0.068).
Conclusion: The rate of HP infection was not higher in patients with epilepsy compared to healthy
individuals. At the moment, there is not enough epidemiological data to support the role of HP infection
in patients with either IGE or TLE.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
InfectionwithHelicobacter pylori (H. pylori) is themost common
chronic bacterial infection in human. H. pylori infection has been
detected worldwide and among all age groups. Conservative
estimates suggest that 50% of the world’s population is infected.
Infection is more frequent and acquired at an earlier age in
developing countries compared to industrialized nations. Once
acquired, infection persists and may or may not cause gastroin-
testinal disease.1
The possible role of H. pylori infection in extra-intestinal
diseases such as idiopathic thrombocytopenia purpura, acute
coronary heart disease, Alzheimer disease, and even patients with
epilepsy has been investigated and suggested.2–6 The possible
reason that H. pylori infection causes or relates to extra-intestinal
diseases could be due to immunological mechanisms involved.4 It* Corresponding author at: Department of Neurology, Shiraz University of
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doi:10.1016/j.seizure.2011.08.011has been speculated that, H. pylori, by inducing pro-inﬂammatory
cytokine [interleukin (IL)-1 and -6, or tumor necrosis factor (TNF)-
a] production and blood–brain barrier disruption, might inﬂuence
the pathophysiology and therefore the management of epilepsy.7
On the other hand, for many patients with epilepsy no certain
cause for seizure could be found, even after extensive investiga-
tions. The situation in these patients is considered as idiopathic. An
idiopathic epilepsy syndrome is usually presumed to be genetic,8
however other unidentiﬁed, unknown causes could not be ruled
out yet.
The main purpose of this study was to determine the frequency
of infection with H. pylori among two groups of patients with
epilepsy: patients with idiopathic generalized epilepsy (IGE) and
patients with temporal lobe epilepsy (TLE) due to mesial temporal
sclerosis.
2. Methods and materials
In this cross-sectional study a random sample of adult patients
above 18 years of age with an electro-clinical diagnosis of IGE or
TLE were recruited at the outpatient epilepsy clinic at Shiraz
University of Medical Sciences, which is the only epilepsy clinic invier Ltd. All rights reserved.
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epilepsy wasmade based on the clinical grounds and EEG ﬁndings,
and all patients had to be under the care of the epileptologist at our
institution. Patients with IGE had absences, myoclonic jerks or
generalized tonic–clonic seizures, alone or in combination and
their EEG showed spike-wave complexes and/or polyspikes.
Patients with TLE had the typical semiology and their EEG showed
temporal epileptiform discharges. MRI was available in patients
with TLE and showed mesial temporal sclerosis in all. A group of
healthy individuals (healthy relatives or care-givers of patients
with stroke) attending our general neurology clinic in the same
time period and with similar socioeconomic status were included
as control group. With regard to socioeconomic status, we did not
use any particular tool, butwe believe that the patients referring to
our epilepsy clinic (cases) and the patients referring to our general
neurology clinic (their healthy care-givers were controls) have
similar socioeconomic status. For all patients and controls a urea
breath test (UBT) was requested. None of the participants took any
of the medications with possible interaction with UBT (e.g.,
omeprazol and antibiotics).
Age, gender, seizure type(s), EEG ﬁndings and ﬁnal syndromic
diagnosis of all patients were registered routinely. Demographic
variables and relevant clinical and EEG variables were summarized
descriptively to characterize the study population. Statistical
analyses were performed using Pearson Chi square test and t-test
(Independent Samples Test) to determine potentially signiﬁcant
differences, and a P value less than 0.05 was considered signiﬁcant.
This study was conductedwith approval of the Shiraz University of
Medical Sciences Review Board. From all the participants an
informed consent was obtained.
3. Results
Thirty-four patients with IGE, 28 patients with TLE and 33
individuals as control were recruited in the study. Among patients
with IGE, 27 patients were female (79%) and 7 (21%) were male.
Among patients with TLE, 21 patients were female (75%) and 7
(25%)weremale. Control group consisted of 24 females (73%) and 9
(27%) males. There were no signiﬁcant differences between
different groups with regard to sex ratio. The mean age was
23  4 years in patients with IGE. The mean age was 30  9 years in
patients with TLE. The mean age was 32  10 years in control group.
The difference between mean age of patients with TLE was not
statistically signiﬁcant from those in control group (P = 0.3). The
mean age was signiﬁcantly lower in patients with IGE compared to
both control (P = 0.0001) and patients with TLE (P = 0.0001).
Among patients with IGE, UBT was positive in 21 individuals
(61.8%). Positive UBT was observed in 50% (14 patients) of patients
with TLE and 72.7% (24 individuals) in control group. The
difference between patients with IGE and control group with
regard to positive UBT was not signiﬁcant (P = 0.3). The difference
between patients with TLE and control group with regard to
positive UBT was not signiﬁcant either (P = 0.068). The difference
between patients with IGE and patients with TLE with regard to
positive UBT was not signiﬁcant (P = 0.3).
4. Discussion
Unidentiﬁed, unknown causes are responsible for some cases or
syndromes of epilepsy and searching for these possible etiologies
may help understand and manage these syndromes more
successfully. The relationship between chronic H. pylori infection
and extra-intestinal diseases is known. This relationship is
probably associated with immunological mechanisms.4,9 In two
previous studies, it was observed that H. pylori infection was more
frequent in patients with epilepsy compared to healthy control4and patients with other chronic disorders.5 In the current study,
the rate of H. pylori infection was not higher in patients with
epilepsy compared to healthy individuals. This contradiction could
be due to methodological reasons, at least in part. In both previous
studies, the deﬁnitions for idiopathic5 or cryptogenic4 epilepsy
were not provided adequately and the random nature of those
studies were not discussed (if they were). In addition, the previous
studies used serology (IgG and IgM) and stool antigen assay for
detection of H. pylori infection, but we used UBT. Different studies
have found variable sensitivity (50–100%) and speciﬁcity (76–96%)
for serological tests. The sensitivity and speciﬁcity of stool antigen
assay are 90–94% and 81–92%, respectively. However, some
studies have noted a lower predictive accuracy. The sensitivity
and speciﬁcity of UBT are approximately 88–98% and 89–100%,
respectively. False positive results are therefore uncommon. UBT is
considered as alternative gold standard test (compared with
histology) for detection of H. pylori infection.9–12 The rate of H.
pylori infection was 73% in our control group, which is comparable
to a previous study in Iran. In that previous study, the authors
reported seroprevalence of H. pylori to be 71% among the general
population of Nahavand, in west Iran.13 In another recent study, it
was observed that H. pylori from Iran are similar to others isolated
from Western Eurasia and the authors concluded that they can be
placed in the previously described HpEurope population.14
In conclusion, there is still not enough evidence to believe that
H. pylori might be a potential therapeutic target in epilepsy, in
contrary with that it was hypothesized recently.7 Despite the fact
that searching for unidentiﬁed etiologies of seizures in patients
with epilepsy is imperative, at the moment there is not enough
epidemiological data to support the role of H. pylori infection in
epilepsy syndromes, particularly in patients with either idiopathic
generalized epilepsy or temporal lobe epilepsy. However, it should
be mentioned that a similar H. pylori prevalence between patients
with epilepsy and healthy individuals is not sufﬁcient evidence to
exclude the possibility that this infection might trigger the
appearance or worsens the prognosis of epilepsy either. Further
well-designed studies are required to investigate the relationship
between H. pylori infection and epilepsy, particularly in patients
with refractory seizures.
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